Hiba Muhammed Suza Ali (1), Eman Bekir Al-Khedairy (2)
General Background: Oro-dispersible tablets have emerged as an important advancement in oral solid dosage forms due to their ability to rapidly disintegrate in the oral cavity without water. Specific Background: Their development is driven by patient demand for convenient medication, especially for pediatric, geriatric, and dysphagic populations who experience difficulty swallowing conventional tablets. Knowledge Gap: Despite wide application, comprehensive evaluation of fabrication methods, excipient functions, and characterization parameters across traditional and modern manufacturing technologies remains limited. Aims: This review analyzes the terminology, advantages, limitations, commonly used excipients, manufacturing techniques, and critical quality assessments of ODTs. Results: The study highlights diverse preparation approaches including lyophilization, sublimation, wet granulation, direct compression, mass extrusion, and emerging three-dimensional printing, each offering unique benefits related to disintegration behavior, mechanical strength, and processing efficiency. Novelty: The article synthesizes conventional pharmaceutics knowledge with recent technological innovations such as selective laser sintering and fused deposition modeling, demonstrating how modern techniques enhance precision and personalization of dosage forms. Implications: Findings underscore that optimized excipient selection and manufacturing strategies are fundamental to ensuring rapid disintegration, mechanical stability, acceptable taste, and enhanced bioavailability, reinforcing ODTs as a growing platform for patient-centered drug delivery.Highlight :
Oro-dispersible tablets dissolve rapidly on the tongue, improving convenience for patients with swallowing difficulties.
Formulation uses specific excipients—especially superdisintegrants—to achieve fast disintegration and effective performance.
Can be produced using various traditional and modern manufacturing methods such as direct compression, sublimation, and 3D printing.
Keywords : Disintegration, Oral solid dosage form, Oro-dispersible tablet, Patients’ compliance, Manufacturing techniques
Reddy P. V., Roy S. D., Vasavi G., Sriram N., “Oral Dispersible Tablets – A Review,” International Journal of Pharmaceutical Analysis and Research, vol. 3, no. 1, pp. 22–29, 2014.
Mali R. K., Pawar H. A., Mali K. K., Dias R. J., “Fast Disintegrating Tablets of Olmesartan Medoxomil Using Solid Dispersion Technique,” Asian Journal of Pharmaceutics, vol. 11, no. 2, pp. S425–S433, 2017, doi: 10.22377/ajp.v11i02.1299.
Bonthagarala B., Pasumarthi P., Kiran K. V., Nataraja S., Donthiboina S., “Formulation and Evaluation of Orodispersible Atenolol Maleate Tablets: A Comparative Study on Natural and Synthetic Superdisintegrants,” International Journal of Research in Ayurveda and Pharmacy, vol. 5, no. 2, pp. 185–192, 2014.
Madhumathi I., Hemalatha B., Padmalatha K., “Fast Dissolving Tablets: A Review,” Asian Journal of Pharmaceutical Technology, vol. 12, no. 2, pp. 183–189, 2022, doi: 10.52711/2231-5713.2022.00031.
Bhardwaj N., “Fast Dissolving Tablets: A Review,” World Journal of Pharmacy and Pharmaceutical Sciences, vol. 11, no. 4, pp. 563–577, 2017.
Tambe B., “Mouth Dissolving Tablets: An Overview of Formulation Technology,” Journal of Innovation in Research and Review, vol. 5, pp. 5451–5459, 2018.
Abay F. B., Ugurlu T., “Orally Disintegrating Tablets: A Short Review,” Journal of Pharmaceutics and Drug Development, vol. 3, no. 3, pp. 1–8, 2015, doi: 10.15744/2348-9782.3.303.
Gujarati N., “Oral Disintegrating Tablets: Background and Review on Recent Advancements,” Advanced Pharmaceutical Journal, vol. 2, no. 2, pp. 54–64, 2017.
Dhahir R., Al-Kotaji M., “Preparation of Cinnarizine Oral Lyophilizates,” Iraqi Journal of Pharmacy, vol. 18, no. 1, pp. 33–43, 2021, doi: 10.33899/iphr.2021.168800.
Abed K. K., Hussein A. A., Ghareeb M. M., Abdulrasool A. A., “Formulation and Optimization of Orodispersible Tablets of Diazepam,” AAPS PharmSciTech, vol. 11, no. 1, pp. 356–361, 2010, doi: 10.1208/s12249-010-9387-y.
Darade S. C., Patil P. B., Kalkotwar R. S., “Formulation and Evaluation of Orodispersible Tablets Containing Piroxicam by Sublimation Method,” Indian Journal of Pharmacy and Pharmacology, vol. 4, no. 2, pp. 77–82, 2017, doi: 10.18231/2393-9087.2017.0019.
Al-Gawhari F. J., Mohammed A. A., “Types of 3D Printers Applied in Industrial Pharmacy and Drug Delivery: Review Article,” Technium BioChemMed, vol. 3, no. 2, pp. 1–14, 2022, doi: 10.47577/biochemmed.v3i2.6064.
Allahham N., et al., “Selective Laser Sintering 3D Printing of Orally Disintegrating Printlets Containing Ondansetron,” Pharmaceutics, vol. 12, pp. 1–13, 2020, doi: 10.3390/pharmaceutics12020110.
Kumar R. S., Devi M. G., “Review Article on Fast Dissolving Tablets,” International Journal of Health Sciences, vol. 6, no. S2, pp. 13684–13698, 2022, doi: 10.53730/ijhs.v6nS2.8960.
Prabhat S., Rajan S., Sahana S., “Formulation and Evaluation of Orally Disintegrating Tablet Containing Taste-Masked Mirtazapine,” Journal of Analytical and Pharmaceutical Research, vol. 10, no. 2, pp. 71–80, 2021, doi: 10.15406/japlr.2021.10.00368.
Bharpoor S., Bains R., Singh N. S. G., “Mouth Dissolving Tablets: An Innovative Deviation in Drug Delivery System,” Journal of Pharmaceutical Sciences and Research, vol. 11, no. 4, pp. 1186–1194, 2019.
Rai K., Jain V., Jain S. K., Khangar P. K., “Formulation and Evaluation of Taste-Masked Oral Disintegrating Tablets of Lornoxicam,” Journal of Drug Delivery and Therapeutics, vol. 11, no. 5, pp. 115–120, 2021, doi: 10.22270/jddt.v11i5.5124.
Shanmugam S., “Granulation Techniques and Technologies: Recent Progresses,” BioImpacts, vol. 5, no. 1, pp. 55–63, 2015, doi: 10.15171/bi.2015.04.
Ahmed D. K., Kaamal B. A., “Formulation and Optimization of Oral Fast Dissolving Prochlorperazine Maleate Tablets,” Iraqi Journal of Pharmaceutical Sciences, vol. 21, no. 1, pp. 46–55, 2012, doi: 10.31351/vol21iss1pp46-55.
Gupta M. K., Sharma S., Gupta M., Sen P., “Formulation and Evaluation of Fast Dissolving Tablets,” International Journal of Current Pharmaceutical Review and Research, vol. 13, no. 3, pp. 13–19, 2021.
Parkash V., et al., “Fast Disintegrating Tablets: Opportunity in Drug Delivery System,” Journal of Advanced Pharmaceutical Technology and Research, vol. 2, p. 223, 2011.
Bhatti S., Kaushik M., “Utilization of Natural Superdisintegrant in Fast Dissolving Tablet: A Simplified Review,” International Journal of Biological Pharmacy and Allied Sciences, vol. 8, no. 2, pp. 32–38, 2022.
Mhaske N. S., Prakash W. P., “Fast Dissolving Tablets: A Review of Formulation and Evaluation Strategies,” International Journal of Creative Research Thoughts, vol. 12, no. 4, pp. 440–453, 2024.
Abd Al Hammid S. N., “Preparation and Evaluation of Sodium Fluoride Orodispersible Tablets,” Kerbala Journal of Pharmaceutical Sciences, vol. 5, pp. 46–55, 2013.
Dave V., Yadav R. B., Ahuja R., Sahu A. K., “Formulation and Evaluation of Orally Dispersible Tablets of Chlorpheniramine Maleate by Fusion Method,” Marmara Pharmaceutical Journal, vol. 21, pp. 67–77, 2017, doi: 10.12991/marupj.259883.
Lakshmi P. K., Kumar D. V., Harin K., “Formulation and Evaluation of Oro-Dispersible Tablets Using Modified Polysaccharides,” Saudi Journal of Medical and Pharmaceutical Sciences, vol. 3, no. 1, pp. 13–22, 2017, doi: 10.36348/sjmps.
Abdulqader A. A., Al-Khedairy E. B., “Formulation and Evaluation of Fast Dissolving Tablets of Taste-Masked Ondansetron Hydrochloride by Solid Dispersion,” Iraqi Journal of Pharmaceutical Sciences, vol. 26, no. 1, pp. 50–60, 2017, doi: 10.1234/ijps.v26i1.685.